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Abstract
The prevalence of infectious diseases is becoming a worldwide problem, and antimicro-
bial drugs have long been used for prophylactic and therapeutic purposes, but bacte-
rial resistance has creating serious treatment problems. The development of antibiotic 
resistance makes scientists around the world to seek new drugs that would be more 
effective. The use and search for drugs obtained from plants and other natural prod-
ucts have increased in recent years. It is well known that silver and its compounds have 
strong antibacterial activity. Silver, compared to the other metals, shows higher toxicity 
to microorganisms, while it exhibits lower toxicity to mammalian cells. The progress in 
the field of nanotechnology has helped scientists to look for new ways in the develop-
ment of antibacterial drugs. Silver nanoparticles (AgNPs) are interesting for their wide 
range of applications, e.g. in pharmaceutical sciences, which include treatment of skin 
diseases (e.g. acne and dermatitis) and other infectious diseases (e.g. post-surgical infec-
tions). Various antibacterial aids, such as antiseptic sprays, have also been developed 
from AgNPs. In this chapter, we have focused on various synthesis methodologies of 
AgNPs, antibacterial properties, and the mechanism of action.
Keywords: silver nanoparticles, plant extracts, antibacterial activity, green synthesis, 
biosynthesis
1. Introduction
Frequent use of antibiotics results in resistance of pathogens against them. This is the health 
and the life-threatening reality. It is therefore necessary to look for new sources of effective 
potent drugs. Nature is an inexhaustible source of health-promoting substances. Combination 
of knowledge in natural medicine with modern technology leads to the discovery of new 
drugs. One of the most promising sources in recent years has been shown to be plant extracts, 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the t rms of the Crea ive
Comm ns Attribution Lic nse (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
which are rich in antioxidant and antimicrobial compounds that have been used as a nanopar-
ticle synthesis agent [1–3]. Nanotechnology and nanoscience have been established recently 
as an interdisciplinary subject dealing with biology, chemistry, physics, and engineering. The 
term “nano” is derived from the Greek word dwarf in the meaning of extremely small. The 
size of nanoparticle is between 1 and 100 nm [4, 5]. Unique biological, chemical, and physical 
properties of silver nanoparticles (AgNPs) lead to the wide range of applications in spec-
troscopy, sensors, electronics, catalysis, and pharmaceutical purposes [6]. It is well known 
that silver has an inhibitory effect toward many bacterial strains and microorganisms com-
monly presented in medical and industrial properties [7], e.g. in the medical industry includ-
ing creams containing silver to prevent local infections of burns or open wound, dental work, 
catheters, plastics, soaps, pastes, and textiles [8–11]. Many authors confirmed that AgNPs 
show efficient antimicrobial properties and kill bacteria at low concentrations (mg L−1) [12] 
without toxic effect on human cells [13, 14].
The presented review deals with the possibilities of the synthesis of AgNPs with respect 
to green synthesis as well as their antimicrobial activity and its determination. Finally, we 
focused on the mechanism of action theories of silver nanoparticles.
2. Synthesis of silver nanoparticles
Production of nanoparticles can be achieved through different methods. Generally, we can 
divide these methods into physical, chemical, and biological. Some of these methods are sim-
ple and make good control of nanoparticle size by affecting the reaction process. On the other 
side, there are still problems with stabilization of the product and in obtaining monodisperse 
nanosize using achieved method [15]. In Table 1, we show list of some synthesis techniques 
of AgNPs and some of them are further briefly described.
2.1. Physical and chemical methods
For a physical approach, the nanoparticles are prepared using evaporation-condensation, 
which could be carried out in a tube furnace at atmospheric pressure [16]. This method has 
Silver nanoparticles synthesis
Physical methods Chemical methods Green synthesis methods
In vitro methods In vivo methods
Pulsed laser ablation
Evaporation-condensation
Spray pyrolysis
Ball milling
Vapor and gas phase
Arc discharge
Reduction
Sonochemical
Photochemical
Electrochemical
Microwave
Using microorganisms
Using plant extracts
Using biomolecules
Using algae
Using mushroom extracts
Using essential oils
Using plant
Using microorganisms
Using yeast
Using algae
Table 1. Selected techniques for the preparation of AgNPs.
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some disadvantages due to large space of tube furnace, high energy consumption, and long 
time for achieving thermal stability. For these reasons, various methods of synthesis of AgNPs 
by physical methods were developed, for example, a thermal decomposition for the prepara-
tion of nanoparticles in powder form [17]. Conventional physical methods, such as pyrolysis, 
were used by Pluym et al. [18]. The advantages of physical methods are speed and no use of 
toxic chemicals, but there are also some disadvantages, such as low yields and high energy 
consumption [19].
Chemical methods provide an easy way to prepare AgNPs in solution (water or organic solvent 
could be used). The most common method of synthesis of silver nanoparticles is reduced by 
organic and inorganic reducing agents. Generally, various reducing compounds, such as sodium 
ascorbate, sodium borohydride, hydrogen, Tollens reagent, and N,N-dimethylformamide, 
could be used for Ag+ ion reduction. The reduction leads to the formation of metallic silver Ag0, 
which is followed by agglomeration into oligomeric clusters. These clusters eventually lead to 
the formation of metallic colloidal silver particles [20]. It is essential to use stabilizing agents 
during the preparation of AgNPs to avoid their agglomeration [21]. It is necessary to note that 
polymeric compounds such as poly (vinyl alcohol), poly (vinyl pyrrolidone), and polyethylene 
glycol are effective protecting agents for the stabilization of nanoparticles [22, 23].
2.2. Green synthesis
As we described, there are various chemical and physical methods of synthesis of silver 
nanoparticles. These methods are cost and toxic for the environment [24]. These facts lead 
to the look for new, simple, and eco-friendly alternatives that would not harm human and 
animal health. The revolution in the world of synthesis of silver nanoparticles has brought 
the development of the green synthesis techniques. The biologically provided synthesis of 
nanoparticles has been shown to be simple, low cost, and environmentally friendly. In the 
green synthesis, the reduction procedure is performed by a natural-based material including 
bacteria, fungi, yeast, plants and plant extracts, or small biomolecules (e.g. vitamins, amino 
acids, or polysaccharides) [25–27]. With the development of reliable methodology to produce 
nanoparticles, several attempts of in vivo and in vitro synthesis of AgNPs have been realized. 
In this chapter, we divided the green synthesizing methods into in vivo synthesis, where for 
the biogenic production of silver nanoparticles, whole cells were used. In this approach, silver 
reduction can happen intracellularly or extracellularly with the formation of silver nanopar-
ticles on the cell walls. Another case of synthesis of AgNPs is in vitro method. These proce-
dures perform outside of a living organism with a cell-free extract, since the nanoparticles do 
not need whole cells for their synthesis. Generally, the process of biosynthesis involves three 
steps. The first step is, the phase of reduction of Ag+ ions; the second is growth step, where 
larger aggregates are observed; and finally, the third, in which the stabilization of nanopar-
ticles with capping agents is proceeded [28]. In Table 2, we reported the most recently pub-
lished green synthesis of silver nanoparticles.
2.2.1. In vitro synthesis of AgNPs
In the so-called green approach, the reduction procedure is performed by a natural-based 
material, most commonly a plant extract containing substances with the antioxidant and 
Green-Synthesized Silver Nanoparticles and Their Potential for Antibacterial Applications
http://dx.doi.org/10.5772/intechopen.72138
75
Species Reducing/
capping agent
Precursor Charac. 
techn.
Tested bacteria Method Ref.
Plants
Pelargonium 
endlicherianum
Root extract 5 mM 
AgNO
3
SEM
UV/Vis
DLS
Zeta pot.
G-: E. coli, 
Pseudomonas 
aeruginosa
G+: Staphylococcus 
epidermidis
Microdilution 
method, MIC
[66]
Lantana camara Terpenes-rich 
extract of leaf
1 mM 
AgNO
3
XRD
UV/Vis
FTIR
SEM
Zeta pot.
G-: E. coli, 
Pseudomonas 
aeruginosa
G+: Staphylococcus 
aureus
Agar well-
diffusion 
method
[63]
Diospyros sylvatica Root extract 10 mM 
silver 
acetate
UV/Vis
SEM
TEM
XRD
G-: E. coli, Klebsiella 
pneumoniae, 
Pseudomonas 
aeruginosa, Proteus 
vulgaris
G+: Bacillus subtilis, 
Bacillus pumilis, 
Streptococcus pyogenes, 
Staphylococcus aureus
Macrodilution 
broth method, 
MIC
[67]
Adhathoda vasica Leaf extract 50 mM 
AgNO
3
UV/Vis
XRD
SEM
TEM
G-: Salmonella 
typhimurium
G+: Bacillus subtilis
Agar diffusion 
method
[68]
Carica papaya Peel extract 0.25–1.25 
mM 
AgNO
3
UV/Vis
FTIR
XRD
DLS
AFM
Zeta pot.
G-: E. coli, Klebsiella 
pneumoniae
G+: Staphylococcus 
aureus, Bacillus subtilis
Disc-diffusion 
method
[61]
Alstonia scholari Leaf extract 1 mM 
AgNO
3
UV/Vis
XRD
EDS
SEM
AFM
FTIR
G-: E. coli, 
Pseudomonas sp., 
Klebsiella sp.
G+:Bacillus sp., 
Staphylococcus sp.
Agar well-
diffusion 
method
[69]
Ocimum 
tenuiflorum, 
Solanum 
tricobatum, 
Syzygium cumini, 
Centella asiatica, 
Citrus sinensis
Leaves/peel 
extract
1 mM 
AgNO
3
UV/Vis 
XRD
AFM SEM
G-: E. coli, 
Pseudomonas 
aeruginosa, Klebsiella 
pneumoniae
G+: Staphylococcus 
aureus
Agar well-
diffusion 
method
[70]
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Species Reducing/
capping agent
Precursor Charac. 
techn.
Tested bacteria Method Ref.
Ficus religiosa Leaf extract 1 mM 
AgNO
3
TEM
UV/Vis
EDX
FTIR
DLS
DSC
Zeta pot.
G-: E. coli, 
Pseudomonas 
fluorescens, Salmonella 
typhi
G+: Bacillus subtilis
Disc-diffusion 
method
[71]
Tamarindus indica Fruit extract 5 mM 
AgNO
3
UV/Vis
XRD
EDX
SEM
TEM
FTIR
G-: Pseudomonas 
aeruginosa, Salmonella 
typhi, E. coli, Klebsiella 
pneumonia
G+: Bacillus cereus, 
Staphylococcus aureus, 
Micrococcus luteus, 
Bacillus subtilis
Agar diffusion 
method
[72]
Alfalfa In vivo seeds AgNO
3
XRD
TEM
— — [52]
Mushrooms
Pleurotus ostreatus Water extract 1 mM 
AgNO
3
UV/Vis
SEM
TEM
EDX FTIR
G-: E. coli, 
Pseudomonas 
aeruginosa
G+: Bacillus subtilis, 
Bacillus cereus, S. 
aureus
Disc-diffusion 
method, MIC
[34]
Ganoderma neo-
japonicum (Imazeki)
Water extract 1 mM 
AgNO
3
UV/Vis
XRD
TEM
— — [35]
Pleurotus florida Water extract 1 mM 
AgNO
3
UV/Vis
XRD FTIR
TEM
AFM
G-: Salmonella typhi, 
Proteus mirabilis, 
Providencia alcalifaciens
G+: S. aureus
MIC [36]
Larvae
Oecophylla 
smaragdina
Tissue extract 1 M 
AgNO
3
UV/Vis
TEM
EDX
G-: E. coli
G+: S. aureus
Disc-diffusion 
method, MIC
MBC
[73]
Algae
Gracilaria corticata Water extract 1 M 
AgNO
3
UV/Vis
XRD FTIR
TEM
EDS
— — [74]
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Species Reducing/
capping agent
Precursor Charac. 
techn.
Tested bacteria Method Ref.
Pterocladiella 
capillacea
Water extract 1 mM 
AgNO
3
UV/Vis
FTIR
TEM
EDX
G-: E. coli, 
Pseudomonas 
aeruginosa
G+: S. aureus, B. 
subtilis
Agar well-
diffusion 
technique
[64]
Sargassum 
longifolium
Water extract 1 mM 
AgNO
3
UV/Vis
XRD FTIR
SEM
TEM
— — [51]
Bacteria
Acinetobacter spp. Cell-free 
extract
0.5–5 mM 
AgNO
3
UV/Vis
XRD
SEM
TEM
EDS
DLS
G-: E. coli, 
Pseudomonas 
aeruginosa, Enterobacter 
aerogenes, Shigella 
sonnie, Salmonella typhi
G+: S. aureus, 
Streptococcus mutans
Disc-diffusion 
method, MIC
[62]
Bacillus subtilis Culture 
supernat
1 mM 
AgNO
3
UV/Vis
TEM
— — [40]
Klebsiella 
pneumonia, 
Escherichia coli, 
Enterobacter cloacae
Culture 
supernat
1 mM 
AgNO
3
UV/Vis
TEM
EDS
— — [41]
Escherichia coli Culture 
supernat
1 mM 
AgNO
3
UV/Vis
TEM
FTIR
DLS
— — [25]
Pseudomonas 
stutzeri
In vivo 50 mM 
AgNO
3
TEM
EDX
— — [53]
Bacillus cereus Biomass 1 mM 
AgNO
3
UV/Vis
SEM
TEM
EDX
G-: E. coli, 
Pseudomonas 
aeruginosa, Klebsiella 
pneumoniae Salmonella 
typhi
G+: S. aureus
Agar well-
diffusion 
technique
[55]
Fungi
Verticillium Fungal biomass 0.2 mM 
AgNO
3
UV/Vis
TEM
XRD
SEM
EDX
— — [57]
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reducing properties, e.g. aldehydes, ketones, terpenoids, flavones, or carboxylic acids [29]. 
In the field of plant-mediated nanotechnology, various plant extracts of specific parts such 
as root, bark, stem, leaves, seed, fruit, peel, and flower have been used for the synthesis of 
silver nanoparticles [30–32]. In general, silver nitrate aqueous solution is used for the reaction 
with the plant extract leading to rapid formation of stable nanoparticles. The plant extract 
is usually prepared by suspending dried powdered parts of plant in distilled or deionized 
water or organic solvent, most often ethanol and methanol. Extraction is carried out in vari-
ous ways (different temperature, time, extract concentration, and pH). After extraction, the 
solid residues are removed, and the filtrate is used for the synthesis of silver nanoparticles. It 
is investigated that green synthesis using plant extracts is faster than microorganisms, such as 
bacteria or fungi [30]. The biosynthesis of silver nanoparticles from different parts of plants is 
schematically described in Figure 1.
Species Reducing/
capping agent
Precursor Charac. 
techn.
Tested bacteria Method Ref.
Peniclllium 
brevicompactum
Water extract 1 mM 
AgNO
3
UV/Vis
SEM
TEM
FTIR
XRD
— — [39]
Biomolecules
β-Glucan Solution 0.5–1 mM 
AgNO
3
UV/Vis
EDX
TEM
DLS
G-: E. coli, 
Methylobacterium spp., 
Sphingomonas spp.
Disc-diffusion 
method
[75]
Pectin Water solution 1–10 mM 
AgNO
3
TEM
XRD
DSC
TGA
DLS
FTIR
Zeta pot.
G-: E. coli
G+: Staphylococcus 
epidermidis
MIC [26]
Glutathione 1 mM water 
solution
1 mM 
AgNO
3
FTIR
AFM
SEM
G-: E. coli Optical density [46]
DSC: differential scanning calorimetry; EDX: energy dispersive X-ray spectroscopy; TEM: transmission electron 
microscopy; XRD: X-ray diffraction; TGA: thermogravimetric analysis; DLS: dynamic light scattering; Zeta pot.: Zeta 
potential; SEM: scanning electron microscopy; EDS: energy dispersive spectroscopy; AFM: atomic force microscopy; 
FTIR: Fourier-transform infrared spectroscopy; MIC: minimum inhibitory concentration; UV/Vis: ultraviolet and visible 
spectroscopy; G−: Gram-negative bacteria; G+: Gram-positive bacteria.
Table 2. Green synthesized AgNPs and their antibacterial activity, if determined.
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It is well known that edible mushrooms are rich in proteins, saccharides, vitamins, amino 
acids and other compounds, which can be used as reducing agents in biosynthesis of silver 
nanoparticles. The aqueous extract of edible mushroom Volvariella volvacea was used for the 
synthesis of AgNPs. Author thought that as mushrooms are rich in proteins, there is increased 
productivity of nanoparticles compared to other biosynthesis routes already reported [33]. 
In recent time, there has been published another papers that described green synthesis from 
mushroom extracts, for example, Pleurotus ostreatus [34], Ganoderma neo-japonicum [35], and 
Pleurotus florida [36].
Interestingly, the use of microorganism extract has resulted in an easy method to synthesize 
nanoparticles with characteristic shapes, size, and morphology. Extracts from microorgan-
isms (fungi, bacteria, yeasts, actinomycetes) may act as reducing and capping agents for the 
synthesis of AgNPs. The reduction of Ag+ ions is proceeded by biomolecules found in extract 
(enzymes, proteins, amino acids, polysaccharides or vitamins). In case of microorganisms, 
the extracts can be made by two methods. The first is by washing the biomass and dissolv-
ing the cells in water or a buffer [37], and the second is by used medium in which biomass 
has grown [38]. The aqueous extract from a fungus Penicillium brevicompactum was attempted 
[39]. Of course, specific bacteria can be used for the synthesis of nanoparticles. An interesting 
approach of green biosynthesis of AgNPs using supernatant of Bacillus subtilis and microwave 
irradiation in water solution has been studied [40]. Authors reported extracellular biosynthe-
sis of silver nanoparticles and avoid the aggregation of microwave radiation they used. The 
rapid biosynthesis of AgNPs using the bioreduction of aqueous Ag+ ion by the culture super-
natants of Klebsiella pneumonia, Escherichia coli, and Enterobacter cloacae was reported [41]. An 
extensive volume of literature reported successful biosynthesis of AgNPs using microorgan-
isms including bacteria, fungi, yeasts, and actinomycetes.
Figure 1. Schematic representation of synthesis of silver nanoparticles.
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Reduction of Ag+ ions is achieved using biomolecules that also serve as a capping agent. 
Reaction is mostly performed in water solution, which is considered as environmentally 
friendly solvent system. The extraction and purification of biomolecules require one or more 
steps in production process, and for this reason, it could be needed more time and would be 
not economic. The solution of this problem is using simple molecules, such as saccharides and 
polysaccharides as reducing agents. A simple method for silver nanoparticles was described 
by Raveendran et al., who used α-D-glucose as reducing agent in gently heated system [42]. In 
another work, the AgNPs were synthesized using pectin from citrus [26]. Authors found opti-
mal conditions and some advantages, such as short reaction time, almost 100% conversion of 
Ag+ ion to Ag0 and very good reproducibility and stability of the product. There were used 
many approaches using polysaccharides for synthesis of AgNPs, e.g. dextrin [43], cellulose 
[44], or polysaccharides isolated from marine macro algae [45]. Preparation of silver nanopar-
ticles using other isolated or purified biomolecules has also been studied. For example, as 
reducing and capping agents were used glutathione [46], tryptophan residues of oligopep-
tides [47], natural biosurfactants [48], oleic acid [49], etc.
Essential oils could be one of the alternative methods for biosynthesis of AgNPs. With respect 
to chemical composition of essential oils (phenols, flavonoids, terpenes), essential oils have 
been successfully used for the preparation of silver nanoparticles. Usually, reduction is 
used for aqueous solution of silver nitrate, and essential oils serve as reducing and capping 
agents [50].
Algae extracts have great efficiency in green synthesis of nanoparticles. There have been a 
few articles published reporting this method. Rajeshkumar and his co-workers published 
an algae-mediated preparation of AgNPs using purified brown algae Sargassum longifolium 
water extract. The extract was mixed with silver nitrate water solution and kept at the room 
temperature [51]. Bioreduction of Ag+ ions by algae extracts is similarly proceeded due to 
content of phytochemicals (carbohydrates, alkaloids, polyphenols, etc.).
2.2.2. In vivo synthesis of AgNPs
Under the term in vivo, we understand the biosynthesis of nanoparticles in living organisms, 
either extracts or isolated biomolecules. Gardea-Torresdey published the very first article dis-
cussing about synthesis of silver nanoparticles using living plant Alfalfa (Medicago salvia). 
They found that Alfalfa root is able to absorb silver in neutral form (Ag0) from agar medium 
and transport it into the shoots of plant where Ag0 atoms arrange themselves to produce 
AgNPs [52]. Marchiol et al. [28] reported the in vivo formation of silver nanoparticles in plants 
Brassica juncea, Festuca rubra, and Medicago sativa. The rapid bioreduction was performed 
within 24 h of exposure to AgNO
3
 solution. TEM analyses indicated the in vivo formation of 
AgNPs in the roots, stems, and leaves of the plants, which had a similar distribution but dif-
ferent sizes and shapes. The contents of reducing sugars and antioxidant compounds were 
proposed to be involved in the biosynthesis of AgNPs.
Some microorganisms resistant to metal can survive and grow in the presence of metal 
ions. The first evidence of bacteria synthesizing silver nanoparticles was observed using 
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Pseudomonas stutzeri AG259 strain [53]. Since the first evidence of bacteria producing AgNPs 
in 1999, different bacteria were used, e.g. Lactobacillus strains [54], E. coli [25], or Bacillus cereus 
[55]. Fungi have been observed as good producers of silver nanoparticles due to their toler-
ance and capability of bioaccumulation of metals. When fungus is exposed to the Ag+ ions, it 
produces enzymes and metabolites, which protect it from undesirable foreign matters result-
ing in production of AgNPs [56]. Many reports dealing with biosynthesis of silver nanopar-
ticles using fungi or yeasts have been published. For example, fungus-mediated synthesis of 
silver nanoparticles was described by Mukherjee [57]. They isolated the fungus Verticillium 
from the Taxus plant, and after mycelia growth and separation, they suspended dry mycelia 
in distilled water and added the Ag+ ions to prepare silver nanoparticles. They found that 
the AgNPs were formed below the cell wall surface due to reduction of silver ions (Ag+) by 
enzymes presented in the cell wall membrane. Extracellular production of silver nanopar-
ticles was described, for example, by Sadowski, who prepared nanoparticles from Penicillium 
fungi isolated from the soil [58].
3. Antibacterial activity
The discovery of the first antibiotics has dramatically changed the quality of human life, but 
the development of the natural mechanism of bacterial resistance has been forced scientists 
to develop more effective antimicrobial drugs. The interest about the use of nanoparticles as 
antibacterial agents has seen a dramatic increase in the last few decades. The unique proper-
ties of silver nanoparticles have allowed exploiting in medicinal field. The most studies have 
been attended to their antimicrobial nature. Since silver nanoparticles show promising anti-
microbial activity, researchers use several techniques to determine and quantify their activity 
on various Gram-positive and Gram-negative bacteria.
3.1. Methods of evaluation of antibacterial activity
To evaluate the antimicrobial activity different methods are currently used, the results of 
which are given in different ways. Commonly used techniques to determine the antimicro-
bial activity of biogenic silver are the minimal inhibitory concentration (MIC), the minimal 
bactericidal concentration (MBC), time-kill, the half effective concentration (EC
50
), well-
diffusion method, and disc-diffusion method. The most commonly used is disc-diffusion 
method developed in 1940. These well-known procedures are comprised of preparation of 
agar plates incubated with a standardized inoculum of test microorganism. Then, the sterile 
discs (about 6 mm in diameter) impregnated with AgNPs at a desired concentration are 
placed on the agar surface. According to agar well-diffusion method, the tested concentra-
tion of AgNPs is introduced into the well with a diameter of 6–8 mm punched into agar. 
Cultured agar plates are incubated under conditions suitable for tested bacteria, and the 
sensitivity of the tested organisms to the AgNPs is determined by measuring the diameter 
of the zone of inhibition around the disc or well. This method is contributed and beneficial 
for its simplicity and low cost and is commonly used in antibacterial activity of Ag nanopar-
ticles evaluation [59].
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The antibacterial properties of silver nanoparticles are often studied by employing dilution 
methods, quantitative assays, the most appropriate ones for the determination of MIC val-
ues. Minimal inhibitory concentration (MIC) is usually expressed in mg mL−1 or mg L−1 and 
represents the lowest concentration of the AgNPs, which inhibits the visible growth of the 
tested microorganism. Either broth or agar dilution method may be used for quantitative 
measurement, the in vitro antimicrobial activity against bacteria. The minimum bactericidal 
concentration (MBC) is less common compared to MIC determination and is defined as the 
lowest concentration of antimicrobial agent killing 99.9% of the final inoculum after incu-
bation for 24 h. The most appropriate method for determining the bactericidal effect is the 
time-kill test and can be also used to determine synergism for combination of two or more 
antimicrobial agents. These tests provide information about the dynamic interaction between 
different strains of microorganism and antimicrobial agents. The time-kill test reveals a time-
dependent or a concentration-dependent antimicrobial effect. The varied time intervals of 
incubation are used (usually 0, 4, 6, 8, 10, 12, and 24 h), and the resulting data for the test are 
typically presented graphically [59].
3.2. Antibacterial activity of AgNPs
Antimicrobial activity of silver is well known. Silver has been used for treatment of several dis-
eases since from ancient time [60]. The AgNPs synthesized by different methods were widely 
tested against number of pathogenic bacteria with evidence of strong antimicrobial activity 
against a broad-spectrum bacteria including both Gram-negative and Gram-positive. Some 
researchers have been reported that the AgNPs are more effective against Gram-negative bacteria 
[61–63], while opposite results have also been found [64]. The difference in sensitivity of Gram-
positive and Gram-negative bacteria against AgNPs may result from the variation in the thick-
ness and molecular composition of the membranes. Gram-positive bacteria cell wall composed of 
peptidoglycan is comparatively much thicker than that of Gram-negative bacteria [2, 65].
The importance of antibacterial activity study on different bacterial strains becomes from the 
importance of understanding the mechanism, resistance and future application. The latest 
studies on antimicrobial properties are summarized in Table 2.
Although the antibacterial effect of silver nanoparticles has been widely studied, there are 
some factors affecting the antimicrobial properties of AgNPs, such as shape, size, and con-
centration of nanoparticles and capping agents [30]. Nakkala et al. [71] analyzed AgNPs with 
the average size of 21 nm, and the size distribution was found to be 1–69 nm prepared by 
medicinal plant Ficus religiosa. These nanoparticles showed excellent antibacterial activity in 
P. fluorescens, S. typhi, B. subtilis, and E. coli. Bacterial cells exposed to lower concentration of 
AgNPs exhibited delays of growth which may be due to the bacteriostatic effect, while at the 
higher concentration (of 60 and 100 μg), the AgNPs were found to exhibit bactericidal effect 
as no growth was observed.
The smaller particles with a larger surface-to-volume ratio were able to reach bacterial proximity 
most easily and display the highest microbicidal effects than larger particles [19, 69, 76]. Normally, 
a high concentration leads to more effective antimicrobial activity, but particles of small sizes can 
kill bacteria at a lower concentration. Furthermore, apart from size and  concentration, shape 
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also influences the interaction with the Gram-negative organism E. coli [19, 77]. Pal et al. [78] 
discussed about depending of nanoparticles’ shape and size on antibacterial activity against 
Gram-negative bacteria E. coli. They found that observed interaction between nanoparticles of 
silver with various shapes and E. coli was similar, and the inhibition results were variable. They 
speculated about the fact that AgNPs with the same surface areas, but different shapes, may 
have unequal effective surface areas in terms of active facets [78]. Sadeghi et al. [79] found dif-
ferent antimicrobial effects of nanosilver shapes (nanoparticles, nanorods, and nanoplates) for 
S. aureus and E. coli. SEM analysis indicated that both strains were damaged and extensively 
inhibited by Ag-nanoplates due to the increasing surface area in AgNPs.
3.3. Mechanism of action
In the past decade, silver nanoparticles as antimicrobial agents have attracted much atten-
tion in the scientific field. Although several reviews have described the AgNPs’ mechanism 
in detail, the exact mechanism of the antibacterial effect of silver and AgNPs remains to be not 
fully elucidated. Most studies considered multiple mechanisms of action but simplified the 
main tree of different mechanisms determine the antimicrobial activity of silver nanoparticles: 
(1) irreversible damage of bacterial cell membrane through direct contact; (2) generation of 
reactive oxygen species (ROS); and (3) interaction with DNA and proteins [80–83]. The dam-
age of cell membranes by AgNPs causing structural changes renders bacteria more perme-
able and disturbs respiration function [84]. Interestingly, Morones et al. [84] demonstrated 
the existence of silver in the membranes of treated bacteria as well as in the interior of it by 
transmission electron microscopy (TEM) analysis. Another aspect of mechanism is the role of 
Ag+ ions release. Research has shown that the Ag+ ions at a lower concentration than that of 
AgNPs can exert the same level of toxicity [60]. Several evidences suggest that the silver ions 
are important in the antimicrobial activity of silver nanoparticles [81, 85]. Durán et al. [81] 
discussed that silver ions react with the thiol groups of proteins, producing bacterial inac-
tivation, and inhibit the multiplication of microorganisms. Ag+ in μmol L−1 levels had weak-
ened DNA replication due to uncoupling of respiratory electron transport from oxidative 
phosphorylation, which inhibits respiratory chain enzymes and/or interferes with membrane 
permeability. On the other side, silver ion can interact with the thiol groups of many vital 
enzymes and inactivate them and generate reactive oxygen species (ROS) [29]. The AgNPs 
can act as a reservoir for the monovalent silver species released in the presence of an oxidizer. 
[85] Ag+ release was found to correlate with AgNP size, the silver nanoparticles antibacte-
rial activity below 10 nm is mainly caused by the nanoparticle itself, while at larger sizes, 
the predominant mechanism occurs through the silver ions [81]. Lee et al. [86] studied the 
mechanism of antibacterial action on Escherichia coli. A novel mechanism for the antibacterial 
effect of silver nanoparticles, namely the induction of a bacterial apoptosis-like response, was 
described. They observed accumulation of reactive oxygen species (ROS), increased intracel-
lular calcium levels, phosphatidylserine exposure in the outer membrane which indicate early 
apoptosis, disruption of the membrane potential, activation of a bacterial caspase-like protein 
and DNA degradation which is the sign of late apoptosis in bacterial cells treated with silver 
nanoparticles (Figure 2).
Antimicrobial activity of silver nanoparticles combined with various antibiotics is currently 
being studied, and the synergistic antibacterial effect has been found. Singh et al. [62] studied 
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individual and combined effects of AgNPs with 14 antibiotics. They found that synergis-
tic action of AgNPs and antibiotics resulted in enhanced antibacterial effect. Exposure of 
bacteria in combination of AgNPs and antibiotics reduced the MICs significantly, and the 
bacteria were found to be susceptible to all of the tested antibiotics, except cephalosporins, 
where no change was observed. The significant reduction of required antibiotic dose up to 
1000-fold in combination with small amount of AgNPs could achieve the same effect. The 
study on bacterial strains resistant to one or more antibiotics belonging to the β-lactam class 
indicated that the addition of AgNPs decreased MIC on the susceptibility range, therefore, 
addition of AgNPs not only reduced MIC, but also caused bacteria sensitivity to antibiotic. 
Briefly, simultaneous action of AgNPs with antibiotics could prevent the development of 
bacterial resistance. These results are in accordance with findings reported by Gurunathan 
[76], who observed synergistic effects of silver nanoparticles in the presence of conventional 
antibiotics on Gram-negative bacteria E. coli and K. pneumoniae. The viability of bacteria was 
significantly reduced by more than 75% in combination of sublethal dose of meropenem and 
AgNPs. Evidence of a synergistic effect resulting from the combination of silver nanopar-
ticles with five different antibiotics was declared by reducing MIC against multiresistant, 
β-lactamase, and carbapenemase producing Enterobacteriaceae [87]. The resistance on anti-
biotic treatment of S. aureus is fast growing global problem due to slow development of new 
effective antimicrobial agents. Akram et al. [88] investigated synergic effect of five various 
antibiotics and AgNPs applied in combination with blue light against methicillin-resistant 
S. aureus (MRSA). These triple combinations of blue light, AgNPs, and the antibiotic consid-
erably enhanced the antimicrobial activity against MRSA, in comparison with treatments 
involving one or two agents.
The biofilm formation is adjunctive problem of resistance on antimicrobial agents and chronic 
bacterial infections. It was proposed that Ag-NPs can impede biofilm formation [89]. Hwang 
et al. [90] found that combination of AgNPs with ampicillin, chloramphenicol, and kana-
mycin against various pathogenic bacteria inhibits the formation of biofilm. Deng et al. [91] 
examined the synergistic antibacterial mechanism of four different classes of conventional 
antibiotics in combination with AgNPs against the multidrug-resistant bacterium Salmonella 
typhimurium. The antibiotics enoxacin, kanamycin, neomycin, and tetracycline interact with 
AgNPs strongly and forming antibiotic-AgNPs complex, while no such effects were observed 
for ampicillin and penicillin. This complex with AgNPs interacts more strongly with the 
Salmonella cells and causes more Ag+ release, thus creating a temporal high concentration of 
Ag+ near the bacterial cell wall that ultimately causes cell death.
Figure 2. Schematic visualization of AgNPs’ mechanism of action.
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4. Conclusion
The use of silver nanoparticles provides an opportunity to solve a global problem of bacte-
rial resistance toward antibiotics. The possibilities of silver nanoparticles synthesis are very 
broad. In the last decade, there has been dramatically grown scientific interest in nanopar-
ticles biosynthesis by various reducing and capping agents presented in biological sources 
including plants, plant extracts, microorganism, or larvae. The natural green synthesis 
approach is an eco-friendly and cost-effective due to the fact that no toxic and dangerous 
chemicals are used.
One of the key aspect in the design of more potent antibacterial system is the understanding 
its mode of action. Generally, nanoparticles are well established as promising alternative to 
antibiotic therapy or combinational therapy because they possess unbelievable potential for 
solving the problem with the development of pathogens resistance. Finally, from this point 
of view, silver nanoparticles represent product with potential application in medicine and 
hygiene, and the green synthesis of AgNPs can pave a way for the same.
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